Jan 5
|
People taking Wegovy and Ozempic have lower risk of suicidal thoughts vs. older drugs, study finds
|
Jan 5
|
Omega (OMGA) Up 95% on Obesity Drug Deal With Novo Nordisk
|
Jan 5
|
Lilly (LLY) Starts Website to Help Access Tirzepatide Drugs
|
Jan 5
|
Novo Nordisk (NVO) Up on $1.1B Research Deals With 2 Biotechs
|
Jan 5
|
Pharma Stock Roundup: LLY's New Digital Pharmacy, NVO & ABBV's Fresh R&D Deals
|
Jan 5
|
Dow Jones Futures Fall Amid Jobs Report As Fed Doubts Grow; Spot Bitcoin ETFs Loom
|
Jan 5
|
Wegovy, Ozempic not linked to increase in suicidal thoughts, US study finds
|
Jan 4
|
Why Novo Nordisk Stock Crushed the Market Today
|
Jan 4
|
Novo Nordisk, The Weight-Loss Kingpin, Breaks Out After Inking Two New Deals In Obesity
|
Jan 4
|
Novo Nordisk enters research partnerships with biotech firms
|
Jan 4
|
The Best Stocks to Invest $1,000 in Right Now
|
Jan 4
|
Here's Why You Should Invest in Adverum (ADVM) Stock Now
|
Jan 4
|
Novo Signs $1.1 Billion Obesity R&D Deals With Two Biotechs
|
Jan 4
|
Wegovy maker Novo Nordisk enters research tie-ups with US biotech firms
|
Jan 4
|
Wegovy maker Novo Nordisk signs research partnerships with U.S. biotech firms
|
Jan 2
|
YEARENDER-Weight-loss drugs: Who, and what, are they good for?
|
Jan 2
|
EXPLAINER-What other health conditions might weight-loss drugs treat?
|
Jan 1
|
Prediction: These 3 Stocks Will Soar in 2024
|
Dec 30
|
Ozempic drugmaker to open AI research hub in King’s Cross
|
Dec 30
|
14 Money Making Stocks To Invest In
|